Pan Chen

11PUBLICATIONS
10CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 24, 2026
LARS2 reprograms mitochondrial metabolism and epigenetically upregulates MHC-I to boost antitumor immunity in nasopharyngeal carcinoma.

|Mar 26, 2026
The cGAS-STING pathway in cancer: friend or foe.

Qian Li, Qingkang Song, Lingli Ma

|Jul 15, 2025
Combining decitabine with radiotherapy to enhance nasopharyngeal carcinoma radiosensitivity via the TFAP2C-OTUD1-SLC25A11 axis.

Haixia Zhang, Siyang Liu, Dan Wang

|Apr 29, 2025
Acetylated KIAA1429 by TIP60 facilitates metastasis and immune evasion of hepatocellular carcinoma via N6-methyladenosine-KDM5B-mediated regulation of FoxO1.

Hu Quan, Huijun Zhou, Fei Chen

|Nov 14, 2024
FOXA1 enhances antitumor immunity via repressing interferon-induced PD-L1 expression in nasopharyngeal carcinoma.

Junshang Ge, Ying Liu, Pan Chen

|Nov 05, 2024
UBR5 metabolically reprograms nasopharyngeal carcinoma cells to promote glycolysis and M2 polarization via SPLUNC1 signaling.

Huai Liu, Yanxian Li, Ling Tang

Pageof 2

Frequent Collaborators

4 joint publications

Hui Wang

2 joint publications

Minghua Yang

2 joint publications

Huai Liu

2 joint publications

Bo Xiang